Post-COVID-19, colonoscopy and FIT usage declined, while stool DNA testing increased among privately insured adults. Screening preferences varied by sex, socioeconomic status, and metropolitan versus ...

Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program We distributed a 21-item survey on cancer screening ...

The novel drug appeared effective in healthy, previously untreated patients, but cost, side effects, and other issues may stand in the way of its widespread use. Compared with German and US patients, ...

The company recently developed a novel, recombinant protein-based chip for identifying protein binding "signatures" in vitro. 1 Candidate pharmaceutical compounds are passed over a prefabricated chip ...

Aflac hopes that every time you see a checkered pattern, you’ll be reminded to get checked for cancer. That’s one ambitious aim of the insurer’s new "Check for Cancer" initiative, which Chief ...